Company Filing History:
Years Active: 1999
Title: The Innovations of Anthony L Albiston
Introduction
Anthony L Albiston is a notable inventor based in North Balwyn, Australia. He has made significant contributions to the field of medical research, particularly in the area of glucocorticoid dehydrogenases. With a total of 2 patents to his name, his work has the potential to impact various medical applications.
Latest Patents
Albiston's latest patents focus on genetic sequences encoding glucocorticoid dehydrogenases and their uses. The first patent describes a nucleic acid molecule encoding a recombinant NAD+ dependent glucocorticoid dehydrogenase, specifically 11 .beta.-hydroxysteroid dehydrogenase-2 (11 .beta.HSD2). This invention is crucial for assaying potential agonists or antagonists of glucocorticoid dehydrogenase activity when expressed in prokaryotic or eukaryotic cells. Furthermore, it relates to immunoreactive molecules that can serve as diagnostic agents for conditions such as hypertension and can aid in predicting outcomes in in vitro fertilization and embryo transfer procedures.
Career Highlights
Albiston is affiliated with the Baker Medical Research Institute, where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical diagnostics and treatments through genetic research.
Collaborations
Some of his notable coworkers include John W Funder and Varuni R Obeyesekere, who have collaborated with him on various research projects.
Conclusion
Anthony L Albiston's contributions to the field of glucocorticoid dehydrogenases exemplify the impact of innovative research in medicine. His patents not only advance scientific knowledge but also hold promise for future medical applications.